Announce Date | 08/07/2025 |
EPS Normalized Actual | $3.57 (Beat by $0.22) |
EPS GAAP Actual | $3.57 (Beat by $0.22) |
Revenue Actual | $2.765B |
Revenue Surprise | Beat by $2765M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 16.79 | 28.7 | 16.60701 | 17.13522 | 1 |
Dec 2026 | 13.93297 | 34.59 | 13.66 | 14.2 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.08 | 3.08 | 2.765B | 4.95% | 2765M |
FQ1 2025 (Mar 2025) | 2.58 | 2.58 | 2.528B | 5.5% | 2528M |
FQ4 2024 (Dec 2024) | 3.66 | 3.66 | 3.011B | 5.41% | 3011M |
FQ3 2024 (Sep 2024) | 3.36 | 3.36 | 2.79B | 13.87% | 2790M |
FQ2 2024 (Jun 2024) | 2.65 | 2.65 | 2.628B | 17.39% | 2628M |
FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 2.389B | 100% | 2389M |
FQ4 2023 (Dec 2023) | 3.58 | 3.58 | 2.848B | 16.68% | 2848M |
FQ3 2023 (Jul 2023) | 2.21 | 2.21 | 2.403B | 100% | 2403M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.44848 | -- | 5.37159 | 5.51164 | 4 |
FQ3 2027 (Sep 2027) | 4.56534 | -- | 4.50091 | 4.61826 | 5 |
FQ2 2027 (Jun 2027) | 4.04781 | -- | 3.99069 | 4.09473 | 2 |
FQ1 2027 (Mar 2027) | 3.4993 | -- | 3.44992 | 3.53986 | 2 |
FQ4 2026 (Dec 2026) | 4.31 | -- | 4.20793 | 4.41481 | 2 |
FQ3 2026 (Sep 2026) | 3.94 | -- | 3.8467 | 4.03581 | 2 |
FQ2 2026 (Jun 2026) | 3.55 | 13.24 | 3.46593 | 3.63633 | 2 |
FQ1 2026 (Mar 2026) | 3.17449 | 18.73 | 3.17449 | 3.17449 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.77B | -- | 3.73B | 3.8B | 5 |
FQ3 2027 (Sep 2027) | 3.36B | -- | 3.32B | 3.39B | 6 |
FQ2 2027 (Jun 2027) | 3.2B | -- | 3.17B | 3.23B | 3 |
FQ1 2027 (Mar 2027) | 2.9B | -- | 2.87B | 2.93B | 3 |
FQ4 2026 (Dec 2026) | 3.38B | -- | 3.31B | 3.44B | 2 |
FQ3 2026 (Sep 2026) | 3.09B | -- | 3.03B | 3.15B | 2 |
FQ2 2026 (Jun 2026) | 2.86B | 3.36 | 2.81B | 2.91B | 2 |
FQ1 2026 (Mar 2026) | 2.65B | 4.73 | 2.65B | 2.65B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.08 | 3.08 | 100% | |
FQ1 2025 (Mar 2025) | 2.58 | 2.58 | 100% | |
FQ4 2024 (Dec 2024) | 3.66 | 3.66 | 100% | |
FQ3 2024 (Sep 2024) | 3.36 | 3.36 | 100% | |
FQ2 2024 (Jun 2024) | 2.65 | 2.65 | 100% | |
FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 100% | |
FQ4 2023 (Dec 2023) | 3.58 | 3.58 | 100% | |
FQ3 2023 (Jul 2023) | 2.21 | 2.21 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $2.77B | $2765M | 100% |
FQ1 2025 (Mar 2025) | $0B | $2.53B | $2528M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.01B | $3011M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.79B | $2790M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.63B | $2628M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.39B | $2389M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.85B | $2848M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.4B | $2403M | 100% |